Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,517,277
-
Share change
-
+224,615
-
Total reported value
-
$223,640,811
-
Price per share
-
$13.54
-
Number of holders
-
60
-
Value change
-
+$1,318,575
-
Number of buys
-
38
-
Number of sells
-
18
Institutional Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q2 2019
As of 30 Jun 2019,
Kiniksa Pharmaceuticals Intern - COM (KNSA) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,517,277 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, HILLHOUSE CAPITAL ADVISORS, LTD., ArrowMark Colorado Holdings LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, BlackRock Inc., Sofinnova Investments, Inc., Vivo Capital, LLC, AMERIPRISE FINANCIAL INC, and FMR LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.